Vijay Garud Bhoj, MD, PhD
Pathology and Laboratory Medicine
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Penn Medicine Provider

About me

  • Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Southwest Texas State University
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Bhoj is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, Scott Jenks, Pedram Bayat, Ki Hyun Kim, Huiwu Zhao, Ositadimma Ugwuanyi, Federico Stella, Guido Ghilardi, Giulia Gabrielli, Sarah McCuaig, Anastasia Iatrou, Elisavet Vlachonikola, Maria Karipidou, Eleni Bouziani, David Espie, Ranjani Ramasubramanian, Andreas Agathangelidis, Aditya Bhosale, Luca Paruzzo, Giovanni Medico, Bronte Kolar, Regina Bugrovsky, Puneeth Guruprasad, Li-Ping Wang, Jaryse Harris, Evgeny Arons, Yunlin Zhang, Raymone Pajarillo, Portia A Kreiger, Chi-Ping Day, S Cenk Sahinalp, Chih Hao Wu, Alessia Santi, Bria Fulmer, Marcos Cases, Matthew B Palmer, Patrizia Porazzi, E John Wherry, Robert J Kreitman, Enrico Tiacci, Sokratis A Apostolidis, Edward M Behrens, Vijay Bhoj, Ignacio Sanz, Giorgio Inghirami, Stephen J Schuster, Paolo Ghia, Kostas Stamatopoulos, Marco Ruella Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells , Science Translational Medicine, 18(835): 2026,eadr9382


Xiuxiu Yang, Qian Xu, Jue Wang, Shanwei Ye, Caroline Markmann, Shujia Zhang, Qian Zhang, Vijay G Bhoj, Liang Huang, Zheng Zhang Engineered extracellular vesicles displaying bi-specific T-cell engagers for targeted therapy of B-cell malignancies , Experimental Hematology & Oncology, 15(1): 2026


Ho M, Paruzzo L, Noll JH, Stella F, Devi P, Ndeupen S, Day YA, Chen GM, Cohen IJ, Ramirez-Fernandez A, Waxman A, Kapur S, Chen F, Xu R, Huff A, Jarocha D, Patel V, Bochi-Layec AC, Ramasubramanian R, Liu S, Bouvier R, de Souza VB, Patel H, Li Z, Carturan A, Michener P, Hopkins CR, Koucky O, Minehart J, Dimitri A, Nabar NR, Hasanali ZS, Ciccarelli BT, Hung P, Williams E, Bartoszek R, Lavorando M, Mohan S, Gonzalez VE, Porazzi P, Bhoj VG, Apostolidis SA, Vogl DT, Porter DL, Scholler J, Diorio C, Roche AM, Everett JK, Bushman FD, Nathanson KL, Stadtmauer EA, Susanibar-Adaniya SP, Garfall AL, Ruella M, Cohen AD, Fraietta JA CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy , Nature Medicine, 32(2): 2026,702-716


Vijay G. Bhoj, Mary Kaminski, Huiwu Zhao, Kyle Jackson, Wei Wang, Chengyang Liu, Robert A. Montgomery, Nicole Ali, Massimo Mangiola, Thomas R. Spitzer, Kassem Safa, Vikram Pattanayak, Raeda Taj, Joy Chiu, Thanh-Mai Bui, Elizabeth M. Sonnenberg, James F. Markmann, Michael C. Milone, Carl H. June, Don L., Siegel, Joseph A. Fraietta, Vanessa Gonzalez, Michela Locci, Matthew Palmer, Dimitri Monos, Wei-Ting Hwang, Tina Sledge, Nancy D. Bridges, Julia S. Goldstein, Jonah Odim, Stuart C. Sweet, Behdad D. Besharatian, Sabiha M. Hussain, Nicholas K. Brown, Malek Kamoun, Alfred L. Garfall, and Ali Naji Kidney Transplant in Two Highly-Sensitized Candidates Post-CAR T Cell Therapy , New England Journal of Medicine (Accepted for publication): 2026


Bernhard Dumoulin, Jonathan Levinsohn, Konstantin Klötzer, Chenyu Li, Liran Mao, Eunji Ha, Samer Mohandes, Thao Nguyen, Luca Paruzzo, Daigoro Hirohama, Victoria Fang, Vijay G Bhoj, Hamideh Parhiz, Magaiver Andrade Silva, Amin Abedini, Andi Bergeson, Daniel Traum, Michael J. May, Klaus H Kaestner, Marco Ruella, Fiona Elizabeth McAllister, Ari A Hakimi, Mingyao Li, Matthew Palmer, E. John Wherry, Christopher A. Hunter, Michael Paul Cancro, TRIDENT consortium, Katalin Susztak Spatial Atlas of Diabetic Kidney Disease Reveals a B-Cell-Rich Subgroup (accepted for publication) , Nature, accepted for publication: 2026


Guruprasad P, Ramasubramanian R, Nason S, Carturan A, Liu S, Paruzzo L, Hornet V, Plesset J, Patel RP, Bhoj V, Beatty GL, Ruella M. Manufacturing of CRISPR-edited primary mouse CAR T cells for cancer immunotherapy , Nature Protocols, 20(12): 2025,3629-3654


Doshi BS, Markmann CA, Novak N, Rojas SJ, Davidson R, Chau JQ, Wang W, Carrig S, Rus CM, Samelson-Jones BJ, Small JC, Bhoj VG*, George LA* Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies , Molecular Therapy, 33(7): 2025,3073-3085


Papadaki GF, Li Y, Monos DS, Bhoj VG Cars pick up another passenger: Organ transplantation , Human Immunology, 86(1): 2024,111180


Lee K, Chau JQ, Suber YB, Sternberg AR, Pishko AM, George LA, Bhoj VG, Doshi BS, Samelson-Jones BJ Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab , Blood, 144(11): 2024,1230-1235


Mack EA, Dougher MC, Ginda A, Cahill CQ, Murter M, Schell K, Tanhehco YC, Bhoj V, Fesnak AD, Siegel DL, Kambayashi T, Aqui N, O'Doherty U Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis , Blood, 143(11): 2024,1049-1054


View all publications